Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up. [electronic resource]
Producer: 20140506Description: 213-7 p. digitalISSN:- 1099-1069
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Clinical Trials as Topic -- statistics & numerical data
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Deoxycytidine -- administration & dosage
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Resistance, Neoplasm
- Drugs, Investigational -- therapeutic use
- Follow-Up Studies
- Humans
- Ifosfamide -- administration & dosage
- Immunologic Factors -- therapeutic use
- Lenalidomide
- Lymphoma, T-Cell, Peripheral -- drug therapy
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Prednisone -- administration & dosage
- Remission Induction
- Salvage Therapy
- Thalidomide -- analogs & derivatives
- Vinblastine -- administration & dosage
- Vinorelbine
- Gemcitabine
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.